Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $6.74M.
ENTERPRISE VALUE (EV)
$6.74M
NeuroSense Therapeutics Ltd.
Market Cap
$6.91M
Enterprise Value (EV)
$6.74M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| NeuroSense Therapeutics Ltd. (NRSN) | $6.91M | $6.74M |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.99M | $15.75M |
| Co-Diagnostics, Inc. (CODX)vs › | $6.82M | $4.96M |
| Mangoceuticals, Inc. (MGRX)vs › | $7.07M | $7.17M |
| Longeveron Inc. (LGVN)vs › | $7.15M | N/A |
| KALA BIO, Inc. (KALA)vs › | $7.16M | $6.93M |
| Aclarion, Inc. (ACON)vs › | $6.66M | N/A |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.24M | $4.58M |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.58M | N/A |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | $5.11M |
Market Cap
$6.91M
Total Debt
$0.00
Cash
$166000.00
Enterprise Value
$6.74M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
